Isomorphic Labs Secures $600M to Transform Drug Discovery with AI

London, March 31, 2025 (Reuters) -- Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital. Google Ventures and Alphabet also participated, reinforcing their ongoing support. The AI startup is positioned to accelerate drug discovery through cutting-edge computational models.

Read full article here.